restart
Life Sciences
Opportunity Expansion R&D Financials INVEST
CSE: HEAL
$1M USD Capital Raise Active

Wellness Made Simple.
Scale Made Global.

Fueling the aggressive United States and South American expansion of the Holy Crap™ product line and launching a revolutionary gut-health beverage.

View Use of Funds Explore Expansion Strategy

Corporate Overview

Building a vertically integrated ecosystem for sustainable growth.

The Holy Crap Acquisition

In February 2026, Restart Life successfully acquired 100% of Holy Crap Foods Inc. for $1M CAD, an established brand generating over $1M in annualized revenue, immediately establishing Restart Life as a revenue-producing organization.

  • ✓ Turnkey Manufacturing: Includes a dedicated, fully functioning production facility in Gibsons, BC, minimizing CAPEX and reducing integration risks.
  • ✓ Extensive Distribution: Existing distribution network across 800+ retail locations in Canada (Metro, Whole Foods, Save-On-Foods, etc.).
  • ✓ Comprehensive Transfer: Includes all IP, proprietary formulations, e-commerce infrastructure, and customer data.

Corporate Structure

Restart Life Sciences is a publicly traded company positioned for aggressive scale through strategic M&A and organic growth in the functional food sector.

Capital Structure (As of Feb 2026)

Shares Outstanding 59,252,354
Reserved for Issuance 13,137,000
CSE: HEAL OTC: NMLSF FSE: HN30

Strategic Expansion Pillars

Capitalizing on our Canadian foundation to penetrate the Americas.

01. United States Market Entry

Deploying capital to localize the Holy Crap brand for the massive US market, including specialized packaging, regulatory compliance, and a multi-channel distribution strategy.

New Product Lines (US specific)

  • High-Protein Line
  • Kids Nutrition Line
  • Seniors Health Line
  • Sports/MMA Collab Line

US Distribution Strategy

Initial launch prioritizing Amazon USA to establish market fit, coupled with establishing a robust US broker network for retail penetration.

02. LATAM Scale (Colombia Hub)

Establishing Medellín, Colombia as the strategic hub for South American operations, lowering production costs while accessing a rapidly growing middle-class market demanding healthy options.

Local Production

Securing regional co-packer agreements and adapting packaging to local market aesthetics and languages.

Secured Partnerships

Top pharmacy chain across Colombia (500+ locations) secured. Network of restaurants and bars in Medellín secured.

R&D Innovation

The "HC" Gut Health Beverage

In partnership with the University of Manitoba Food Sciences Dept., we are developing a revolutionary, soda-style gut health drink. Formulated to meet rigorous Canadian, US, and International standards.

Formulation

Packed with essential probiotics, vitamins, and nutrients specifically tailored to optimize gut flora and digestive health.

The Market

Entering the booming functional beverage market (expected to reach $200B+ globally), providing a healthy alternative to traditional sodas.

  • ✦ Initial launch targeting USA, South America, and Mexico.
  • ✦ Dual-production strategy (USA & South America).
  • ✦ Omnichannel distribution: Organic grocers, boutique stores, Rappi delivery, Amazon.
Prototype
HC
Gut Health Soda
Probiotics
& Vitamins

3D Concept Visualization

Beyond Breakfast.

We are aggressively pursuing targeted merger and acquisition opportunities to further expand our presence in the health and wellness segments, backed by robust R&D and proprietary IP.

Brand Innovation

BrainQ™ & BrainBalls™

Launch of new cognitive health brands focusing on functional snacks designed to support cognitive performance, mental clarity, and sustained energy. Supported by a Joint Venture with Brain Balls Inc.

Tech Infrastructure

AI-Driven E-Commerce

Implementation of an updated AI-driven e-commerce platform incorporating consumer analytics and customer service automation to streamline direct-to-consumer digital operations in the U.S.

Scientific Foundation

Univ. of Manitoba RCFTR

Strategic collaboration with the Richardson Centre for Food Technology and Research (RCFTR) to develop science-driven formulas focusing on cognitive health and the gut-brain axis.

IP Portfolio

Strategic Licensing

IP Conveyance Agreement with Ludwig Enterprises securing mRNA neuro panel testing assets, generating royalty revenues, alongside aggressive trademark licensing for brand expansion.

Revenue Projection
(Post-Injection)

The infusion of $1M USD unlocks multi-market expansion, projecting a 500% increase in sales over 3 years from current annualized revenue.

The Ask

$1,000,000 USD Raise

Targeted capital allocation to drive immediate scale, open new geographic markets, and launch proprietary product lines.

$250k

US Expansion & New SKUs

Development and scaling of existing Holy Crap products into the United States, including all new targeted SKUs (Protein, Kids, Seniors).

  • → Production scaling in Canada
  • → US distribution logistics
  • → Amazon USA inventory stocking
  • → Regulatory and packaging compliance
$250k

"HC" Beverage Development

Full-cycle development of the new gut health beverage, from university R&D to go-to-market execution.

  • → R&D with University of Manitoba
  • → Brand development & Prototypes
  • → Human testing and trials
  • → US Co-packer launch setup
$500k

South American Hub (Colombia)

Capital expenditure to establish full-scale production and distribution operations in Medellín, Colombia.

  • → Factory location and setup
  • → Staffing and regional operations
  • → Distribution network implementation
  • → LATAM logistics management

*Note: Funding requirements and tranches are subject to adjustment based on finalized operational due diligence and raw material cost fluctuations at the time of injection.

restart
Life Sciences

CSE: HEAL | OTC: NMLSF | FSE: HN30

Detailed pro-forma financials and cap table available during due diligence.

© 2026 Restart Life Sciences Corp. All Rights Reserved.

0
Skip to Content
Restart Life
Home
About Us
Our Brands
Investors
News
Contact
CSE: HEAL
Restart Life
Home
About Us
Our Brands
Investors
News
Contact
CSE: HEAL
Home
About Us
Our Brands
Investors
News
Contact
CSE: HEAL

Restart Life Sciences Corp.
997 Seymour Street #230
Vancouver, B.C. Canada V6B 3M1

hello@restartlife.co
(778) 404-0474


Copyright © 2026 Restart Life Sciences Corp.  |  All Rights Reserved. Disclaimer   |  Powered by ridepark.co

Restart Life Sciences Corp.
CSE: HEAL